Table 1. Differential response to measles virus stimulation in high vs. low antibody vaccine responders (genes with q-value <0.15).
Gene symbol | FC lowa | FC low log2b | FC highc | FC high log2d | FC interactione | FC int. log2f | p-valueg | q-value |
---|---|---|---|---|---|---|---|---|
CD93 | 0.06 | -3.99 | 0.41 | -1.28 | 6.55 | 2.71 | <1.0E-13 | <1.0E-09 |
IL24 | 0.75 | -0.42 | 1.52 | 0.6 | 2.02 | 1.02 | 5.80E-13 | 4.55E-09 |
PID1 | 0.01 | -6.5 | 0.14 | -2.83 | 12.78 | 3.68 | 3.34E-11 | 1.75E-07 |
CCL20 | 1.4 | 0.48 | 0.73 | -0.45 | 0.52 | -0.93 | 1.85E-09 | 7.24E-06 |
ITGB8 | 3.73 | 1.9 | 1.71 | 0.77 | 0.46 | -1.13 | 3.78E-08 | 0.0001 |
EHD2 | 0.96 | -0.05 | 0.61 | -0.72 | 0.63 | -0.67 | 5.96E-07 | 0.0016 |
IL6 | 3.1 | 1.63 | 1.53 | 0.61 | 0.49 | -1.02 | 8.77E-07 | 0.0017 |
GPR124 | 0.26 | -1.93 | 0.7 | -0.51 | 2.68 | 1.42 | 9.17E-07 | 0.0017 |
S1PR3 | 1.61 | 0.68 | 1.03 | 0.04 | 0.64 | -0.64 | 9.69E-07 | 0.0017 |
TFPI2 | 1.94 | 0.95 | 0.77 | -0.37 | 0.4 | -1.33 | 1.89E-06 | 0.0027 |
C9orf6 | 0.76 | -0.4 | 0.85 | -0.24 | 1.12 | 0.17 | 1.91E-06 | 0.0027 |
RFX8 | 3.26 | 1.7 | 0.75 | -0.42 | 0.23 | -2.13 | 3.80E-06 | 0.005 |
VNN1 | 0.04 | -4.56 | 0.34 | -1.54 | 8.09 | 3.02 | 6.01E-06 | 0.007 |
CYP3A5 | 0.88 | -0.19 | 0.49 | -1.03 | 0.56 | -0.85 | 6.41E-06 | 0.007 |
BCL2A1 | 2.12 | 1.08 | 1.04 | 0.06 | 0.49 | -1.02 | 8.04E-06 | 0.008 |
SLC35B3 | 1.02 | 0.03 | 0.96 | -0.06 | 0.93 | -0.1 | 9.33E-06 | 0.009 |
SMPDL3A | 1.27 | 0.34 | 0.51 | -0.98 | 0.4 | -1.32 | 1.25E-05 | 0.012 |
NAMPT | 2.3 | 1.2 | 1.04 | 0.05 | 0.45 | -1.15 | 1.90E-05 | 0.017 |
CHST7 | 3.42 | 1.78 | 2.08 | 1.05 | 0.61 | -0.72 | 2.35E-05 | 0.019 |
LIF | 5.23 | 2.39 | 1.37 | 0.45 | 0.26 | -1.93 | 3.41E-05 | 0.027 |
FLT1 | 1.03 | 0.04 | 0.64 | -0.65 | 0.62 | -0.69 | 3.73E-05 | 0.028 |
HTR7 | 0.14 | -2.88 | 0.36 | -1.48 | 2.64 | 1.4 | 4.09E-05 | 0.029 |
VEGFA | 0.82 | -0.29 | 0.46 | -1.12 | 0.56 | -0.83 | 4.91E-05 | 0.033 |
MAP1LC3A | 1.99 | 0.99 | 1.12 | 0.16 | 0.56 | -0.83 | 5.52E-05 | 0.036 |
FAM149B1 | 1.11 | 0.15 | 1.03 | 0.05 | 0.93 | -0.1 | 6.13E-05 | 0.038 |
AK4 | 6.65 | 2.73 | 1.98 | 0.98 | 0.3 | -1.75 | 6.24E-05 | 0.038 |
FPR2 | 1.96 | 0.97 | 0.37 | -1.43 | 0.19 | -2.4 | 8.03E-05 | 0.047 |
SIGLEC15 | 0.14 | -2.87 | 0.83 | -0.27 | 6.09 | 2.61 | 9.11E-05 | 0.051 |
MSC | 8.36 | 3.06 | 3.18 | 1.67 | 0.38 | -1.39 | 0.0001 | 0.054 |
HES1 | 1.34 | 0.42 | 0.82 | -0.29 | 0.61 | -0.72 | 0.0001 | 0.054 |
SGCD | 0.33 | -1.62 | 0.46 | -1.12 | 1.42 | 0.5 | 0.0001 | 0.06 |
CYP1A1 | 4.6 | 2.2 | 1.65 | 0.72 | 0.36 | -1.48 | 0.0001 | 0.066 |
MET | 2.41 | 1.27 | 1 | 0 | 0.42 | -1.27 | 0.0001 | 0.066 |
IL36RN | 78.19 | 6.29 | 12.19 | 3.61 | 0.16 | -2.68 | 0.0001 | 0.066 |
LOC154092 | 1.13 | 0.18 | 0.52 | -0.95 | 0.46 | -1.13 | 0.0001 | 0.066 |
G0S2 | 0.29 | -1.77 | 1.01 | 0.01 | 3.44 | 1.78 | 0.0002 | 0.078 |
OR52N4 | 2.56 | 1.36 | 1.71 | 0.77 | 0.67 | -0.58 | 0.0002 | 0.081 |
TRPA1 | 2.22 | 1.15 | 1.14 | 0.19 | 0.52 | -0.96 | 0.0002 | 0.086 |
LAMB3 | 0.28 | -1.81 | 0.68 | -0.56 | 2.38 | 1.25 | 0.0002 | 0.092 |
ST20 | 0.92 | -0.11 | 0.71 | -0.49 | 0.77 | -0.38 | 0.0003 | 0.101 |
STK31 | 0.95 | -0.08 | 0.71 | -0.49 | 0.75 | -0.42 | 0.0003 | 0.101 |
CCL24 | 0.02 | -5.70 | 0.07 | -3.93 | 3.40 | 1.76 | 0.0003 | 0.109 |
CD33 | 0.07 | -3.93 | 0.13 | -2.97 | 1.95 | 0.96 | 0.0003 | 0.109 |
IL10 | 0.61 | -0.72 | 1.69 | 0.76 | 2.78 | 1.48 | 0.0003 | 0.110 |
LZTS1 | 1.12 | 0.17 | 0.86 | -0.22 | 0.76 | -0.39 | 0.0003 | 0.113 |
ITGB3 | 1.60 | 0.68 | 1.07 | 0.10 | 0.67 | -0.57 | 0.0004 | 0.120 |
DLEU2 | 1.74 | 0.80 | 1.44 | 0.52 | 0.82 | -0.28 | 0.0004 | 0.134 |
STX1A | 0.79 | -0.34 | 0.52 | -0.93 | 0.66 | -0.59 | 0.0004 | 0.135 |
LOC730227 | 1.11 | 0.15 | 0.77 | -0.37 | 0.70 | -0.52 | 0.0005 | 0.146 |
CXCL2 | 0.61 | -0.71 | 1.24 | 0.31 | 2.04 | 1.03 | 0.0005 | 0.146 |
aFold change gene expression for the virus-stimulated PBMCs (low responders) relative to the unstimulated PBMCs (low responders}
bLog2 of the fold change, described in (a).
cFold change gene expression for the virus-stimulated PBMCs (high responders) relative to the unstimulated PBMCs (high responders}.
dLog2 of the fold change, described in (c).
eInteraction fold change is the ratio of the fold change for the stimulated (high responders) relative to unstimulated (high responders) (c) relative to the stimulated (low responders) relative to the unstimulated (low responders) (a)
fLog2 fold change for the interaction (e).
gP-value associated with the test for a gene expression difference in high responders (response to viral stimulation), relative the response of low responders (response to viral stimulation). For CADM1, p-value = 0.0008 and q-value = 0.203